Form 4 for INKT MiNK Therapeutics, Inc.
Accepted 2023-10-03 00:00:00 ET · period of report 2023-09-29 · accession 0000950170-23-051760 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-10-03 | 2023-09-29+ | INKT | Buell Jennifer | CEO, Dir | F - Tax | $1.01 | -148.6K | 992.9K | -13% | -$150.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-29 | F | D | 25,000 | $1.15 | 1,051,465 | D | — | — | (F1) Represents sales of shares, as a consequence of the vesting of restricted stock units, to cover Federal, state and local tax withholding requirements. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.08 to $1.23. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2023-10-03 | F | D | 65,000 | $0.94 | 927,915 | D | — | — | (F3) Represents sales of shares, as a consequence of the vesting of restricted stock units, to cover Federal, state and local tax withholding requirements. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.875 to $1.02. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2023-10-02 | F | D | 58,550 | $1.04 | 992,915 | D | — | — | (F2) Represents sales of shares, as a consequence of the vesting of restricted stock units, to cover Federal, state and local tax withholding requirements. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.99 to $1.20. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |